loadpatents
name:-0.040237903594971
name:-0.027897834777832
name:-0.0082371234893799
MOGI; Muneto Patent Filings

MOGI; Muneto

Patent Applications and Registrations

Patent applications and USPTO patent grants for MOGI; Muneto.The latest application filed is for "methods for treating ocular surface pain".

Company Profile
9.41.51
  • MOGI; Muneto - Waltham MA
  • Mogi; Muneto - Cambridge MA US
  • Mogi; Muneto - Nara-ken JP
  • Mogi; Muneto - Tsukuba JP
  • Mogi; Muneto - Tsukuba-shi JP
  • Mogi; Muneto - Nara JP
  • Mogi; Muneto - Ibaraki JP
  • Mogi; Muneto - Ibaraki-ken JP
  • Mogi, Muneto - Nara-shi JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods For Treating Ocular Surface Pain
App 20220193078 - MEDLEY; Quintus ;   et al.
2022-06-23
Crystalline Forms Of 4-(7-hydroxy-2-isopropyl-4-oxo-4h-quinazolin-3-yl)-benzonitrile And Formulations Thereof
App 20220162170 - BULLOCK; Joseph Paul ;   et al.
2022-05-26
Methods for treating ocular surface pain
Grant 11,234,982 - Medley , et al. February 1, 2
2022-02-01
Methods For Treating Ocular Surface Pain
App 20210275529 - MEDLEY; Quintus ;   et al.
2021-09-09
Formulations of 4-(7-Hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile
App 20200390767 - BULLOCK; Joseph Paul ;   et al.
2020-12-17
Formulations of 4-(7-Hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile
App 20200261457 - BULLOCK; Joseph Paul ;   et al.
2020-08-20
Methods For Treating Ocular Surface Pain
App 20200261456 - MEDLEY; Quintus ;   et al.
2020-08-20
Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activators
Grant 10,550,102 - Adams , et al. Fe
2020-02-04
Methods for treating ocular disease using inhibitors of CSF-1R
Grant 10,537,563 - Adams , et al. Ja
2020-01-21
Methods For Treating Ocular Disease Using Inhibitors Of Csf-1r
App 20190231765 - ADAMS; Christopher ;   et al.
2019-08-01
Indane And Indoline Derivatives And The Use Thereof As Soluble Guanylate Cyclase Activators
App 20190119254 - ADAMS; Christopher M. ;   et al.
2019-04-25
Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activators
Grant 10,208,018 - Adams , et al. Feb
2019-02-19
Method Of Treating Atherosclerosis In High Triglyceride Subjects
App 20180153861 - ARAI; Yoshie ;   et al.
2018-06-07
Cyclohexen-1-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators
Grant 9,957,254 - Adams , et al. May 1, 2
2018-05-01
Method of treating atherosclerosis in high triglyceride subjects
Grant 9,867,811 - Arai , et al. January 16, 2
2018-01-16
Thiophen-2-yl-pyridin-2-yl-1H-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators
Grant 9,765,067 - Adams , et al. September 19, 2
2017-09-19
Indane And Indoline Derivatives And The Use Thereof As Soluble Guanylate Cyclase Activators
App 20170197940 - ADAMS; Christopher M. ;   et al.
2017-07-13
Thiophen-2-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic Acid Derivatives And The Use Thereof As Soluble Guanylate Cyclase Activators
App 20170197950 - ADAMS; Christopher M. ;   et al.
2017-07-13
Cyclohexen-1-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic Acid Derivatives And The Use Thereof As Soluble Guanylate Cyclase Activators
App 20170197941 - ADAMS; Christopher M. ;   et al.
2017-07-13
Substituted aminobutyric derivatives as neprilysin inhibitors
Grant 9,603,819 - Coppola , et al. March 28, 2
2017-03-28
Substituted Aminobutyric Derivatives As Neprilysin Inhibitors
App 20150174089 - COPPOLA; Gary Mark ;   et al.
2015-06-25
Substituted aminobutyric derivatives as neprilysin inhibitors
Grant 9,006,249 - Coppola , et al. April 14, 2
2015-04-14
Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
Grant 8,877,815 - Karki , et al. November 4, 2
2014-11-04
Substituted Aminopropionic Derivatives As Neprilysin Inhibitors
App 20140296240 - COPPOLA; Gary Mark ;   et al.
2014-10-02
Organic compounds
Grant 8,759,365 - Mogi , et al. June 24, 2
2014-06-24
Method Of Treating Atherosclerosis In High Triglyceride Subjects
App 20140134262 - Arai; Yoshie ;   et al.
2014-05-15
Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
Grant 8,642,635 - Iwaki , et al. February 4, 2
2014-02-04
4-benzylamino-1-carboxylacyl-piperidine derivatives as CETP inhibitors
Grant 8,440,682 - Mogi , et al. May 14, 2
2013-05-14
Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
App 20130096168 - IWAKI; Yuki ;   et al.
2013-04-18
Substituted Aminopropionic Derivatives As Neprilysin Inhibitors
App 20130096127 - Coppola; Gary Mark ;   et al.
2013-04-18
Method of inhibiting CETP activity with 4-benzylamino-1-carboxylacyl-piperidine derivatives
Grant 8,420,641 - Mogi , et al. April 16, 2
2013-04-16
Substituted aminopropionic derivatives as neprilysin inhibitors
Grant 8,394,853 - Coppola , et al. March 12, 2
2013-03-12
Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
Grant 8,377,978 - Iwaki , et al. February 19, 2
2013-02-19
Organic Compounds
App 20120264773 - MOGI; Muneto ;   et al.
2012-10-18
Substituted Aminobutyric Derivatives as Neprilysin Inhibitors
App 20120252830 - Coppola; Gary Mark ;   et al.
2012-10-04
Substituted aminobutyric derivatives as neprilysin inhibitors
Grant 8,263,629 - Coppola , et al. September 11, 2
2012-09-11
Organic Compounds
App 20120208816 - MOGI; Muneto ;   et al.
2012-08-16
Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
App 20120202862 - IWAKI; Yuki ;   et al.
2012-08-09
Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
Grant 8,222,286 - Iwaki , et al. July 17, 2
2012-07-17
4-benzylamino-1-carboxylacyl-piperidine derivatives as CETP inhibitors
Grant 8,193,349 - Mogi , et al. June 5, 2
2012-06-05
Substituted Carbamoylcycloalkyl Acetic Acid Derivatives As Nep
App 20120122764 - KARKI; Rajeshri Ganesh ;   et al.
2012-05-17
Tetrahydro-naphthalene derivatives
Grant 8,173,841 - Tajimi , et al. May 8, 2
2012-05-08
Organic compounds
Grant 8,129,411 - Ehara , et al. March 6, 2
2012-03-06
Tetrahydro-naphthalene derivatives
Grant 8,088,826 - Tajimi , et al. January 3, 2
2012-01-03
Tetrahydro-naphthalene Derivatives
App 20110178088 - Tajimi; Masaomi ;   et al.
2011-07-21
Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
App 20110124695 - IWAKI; Yuki ;   et al.
2011-05-26
Organic Compounds
App 20100311750 - Mogi; Muneto ;   et al.
2010-12-09
Substituted Aminopropionic Derivatives as Neprilysin inhibitors
App 20100305131 - Coppola; Gary Mark ;   et al.
2010-12-02
Substituted Aminobutyric Derivatives as Neprilysin Inhibitors
App 20100305145 - Coppola; Gary Mark ;   et al.
2010-12-02
Tetrahydro-Quinolinylurea Derivatives
App 20100137361 - BOUCHON; Axel ;   et al.
2010-06-03
Tetrahydro-quinolinylurea derivatives
Grant 7,683,076 - Bouchon , et al. March 23, 2
2010-03-23
Organic Compounds
App 20090286790 - Imase; Hidetomo ;   et al.
2009-11-19
Tetrahydro-naphthalene and urea derivatives
Grant 7,615,557 - Bouchon , et al. November 10, 2
2009-11-10
Hydroxy tetrahydro-naphthalenylurea derivatives
Grant 7,612,113 - Yura , et al. November 3, 2
2009-11-03
Tetrahydro-Naphthalene Derivatives as Vanilloid Receptor Antagonists
App 20090209514 - Tajimi; Masaomi ;   et al.
2009-08-20
Organic Compounds
App 20090192148 - Ehara; Takeru ;   et al.
2009-07-30
Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists
Grant 7,544,716 - Tajimi , et al. June 9, 2
2009-06-09
Organic Compounds
App 20090118287 - Mogi; Muneto ;   et al.
2009-05-07
Tetrahydro-naphthalene Derivatives
App 20080275047 - Tajimi; Masaomi ;   et al.
2008-11-06
Hydroxy-tetrahydro-naphthalenylurea derivatives
Grant 7,423,175 - Yura , et al. September 9, 2
2008-09-09
3-Mono-and 3,5-Disubstituted Piperidine Derivatives as Renin Inhibitors
App 20080194629 - Baeschlin; Daniel Kaspar ;   et al.
2008-08-14
Tetrahydro-naphthalene derivatives
Grant 7,381,840 - Tajimi , et al. June 3, 2
2008-06-03
Bicyclic Amide, Carbamate or Urea Derivatives as Vanilloid Receptor Modulators
App 20080058377 - Mogi; Muneto ;   et al.
2008-03-06
Tetradydro-Naphthalene And Urea Derivatives
App 20080045546 - Bouchon; Axel ;   et al.
2008-02-21
Tetrahydro-naphthalene and urea derivatives
App 20070167458 - Bouchon; Axel ;   et al.
2007-07-19
Hydroxy-tetrahydro-naphthalenylurea derivatives
App 20070027187 - Yura; Takeshi ;   et al.
2007-02-01
Hydroxy tetrahydro-naphthalenylurea derivatives
App 20060258742 - Yura; Takeshi ;   et al.
2006-11-16
Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists
App 20060135505 - Tajimi; Masaomi ;   et al.
2006-06-22
Tetrahydro-naphthalene derivatives
App 20060128704 - Tajimi; Masaomi ;   et al.
2006-06-15
Urea derivatives
App 20050154230 - Yura, Takeshi ;   et al.
2005-07-14
Imidazopyrimidine derivatives and triazolopyrimidine derivatives
Grant 6,911,443 - Yura , et al. June 28, 2
2005-06-28
Urea derivatives
App 20050119304 - Yura, Takeshi ;   et al.
2005-06-02
Amine derivatives
App 20040259875 - Yura, Takeshi ;   et al.
2004-12-23
Imidazopyrimidine derivatives and triazolopyrimidine derivatives
App 20040054179 - Yura, Takeshi ;   et al.
2004-03-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed